Biemans, V. B. C., Straatmijer, T., Hoentjen, F., & Pierik, M. J. (2021). Letter: Tofacitinib in treatment‐refractory ulcerative colitis—a single centre real‐world experience in Australia. Authors' reply. Alimentary Pharmacology & Therapeutics, 54(4), 534. https://doi.org/10.1111/apt.16505
Chicago Style (17th ed.) CitationBiemans, Vince B. C., Tessa Straatmijer, Frank Hoentjen, and Marieke J. Pierik. "Letter: Tofacitinib in Treatment‐refractory Ulcerative Colitis—a Single Centre Real‐world Experience in Australia. Authors' Reply." Alimentary Pharmacology & Therapeutics 54, no. 4 (2021): 534. https://doi.org/10.1111/apt.16505.
MLA (9th ed.) CitationBiemans, Vince B. C., et al. "Letter: Tofacitinib in Treatment‐refractory Ulcerative Colitis—a Single Centre Real‐world Experience in Australia. Authors' Reply." Alimentary Pharmacology & Therapeutics, vol. 54, no. 4, 2021, p. 534, https://doi.org/10.1111/apt.16505.